0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
Kate Smolina, PhD; Deirdre Weymann, MA; Steve Morgan, PhD; et al.
JAMA. 2015;313(18):1861-1862. doi:10.1001/jama.2015.3642.

The JAMA Forum |  FREE
Austin B. Frakt, PhD
JAMA. 2015;313(11):1091-1092. doi:10.1001/jama.2015.0544.

Viewpoint | 
Rebecca L. Haffajee, JD, MPH; Anupam B. Jena, MD, PhD; Scott G. Weiner, MD, MPH
JAMA. 2015;313(9):891-892. doi:10.1001/jama.2014.18514.
Includes: Supplemental Content

Capitol Health Call | 
Rita Rubin, MA
JAMA. 2015;313(6):558. doi:10.1001/jama.2015.179.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(12):1185. doi:10.1001/jama.2014.12756.

From the JAMA Network | 
Charles Ruetsch, PhD
JAMA. 2014;312(11):1145-1146. doi:10.1001/jama.2014.4318.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(11):1086-1087. doi:10.1001/jama.2014.11153.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(7):684-686. doi:10.1001/jama.2014.9253.

Special Communication |  FREE
Huldrych F. Günthard, MD; Judith A. Aberg, MD; Joseph J. Eron, MD; et al.
JAMA. 2014;312(4):410-425. doi:10.1001/jama.2014.8722.
Includes: Supplemental Content

Medical News & Perspectives | 
Rebecca Voelker, MSJ
JAMA. 2014;312(3):221. doi:10.1001/jama.2014.8845.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Chemotherapy Near the End of Life First—and Third and Fourth (Line)—Do No Harm
Charles D. Blanke, MD; Erik K. Fromme, MD
JAMA Oncology
Original Investigation  | 
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Holly G. Prigerson, PhD; Yuhua Bao, PhD; Manish A. Shah, MD; et al.
JAMA Psychiatry
Editorial  | 
Antipsychotic Use in Youth Without Psychosis A Double-edged Sword
Christoph U. Correll, MD; Joseph C. Blader, PhD
JAMA Psychiatry
Original Investigation  | 
Treatment of Young People With Antipsychotic Medications in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD